Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
This study is currently recruiting participants.
Verified May 2013 by Pfizer
Study NCT01577381   Information provided by Pfizer

First Received on April 11, 2012.   Last Updated on May 6, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Age-Related Maculopathy
Additional conditions recognized in this trial
Atrophy
Geographic Atrophy
Macular Degeneration
More general conditions related to this trial
Eye Diseases
Pathological Conditions, Anatomical
Retinal Degeneration
Retinal Diseases
Interventions listed in this trial
RN6G
Placebo
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services